pharma · Coronary Artery Bypass Grafting · Hypertension Pulmonary Secondary · TENX
TENAX THERAPEUTICS
TENAX THERAPEUTICS, INC.
TENAX THERAPEUTICS is a pharma organization headquartered in Chapel Hill, USA. It trades on NYSE under ticker TENX. Primary therapeutic focus areas include Coronary Artery Bypass Grafting, Hypertension Pulmonary Secondar
Chapel Hill, USA HQ
19 Employees
Public company Type
TENX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Chapel Hill, USA
- Employees
- 19
- Programs
- 7
- Drugs
- 2
- Patents
- 4
Levosimendan
Phase 2 · small molecule · Hypertension Pulmonary Secondary Heart Failure
Levosimendan for Hypertension Pulmonary Secondary Heart Failure is a Phase 2 program (small_molecule) at TENAX THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Internal code TNX-LVO-05
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- TENAX THERAPEUTICS, INC.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Hypertension Pulmonary Secondary Heart Failure
- Status
- completed
- Trials
- 1